news
horos news

Be up to date! Have a look at our most recent news.

117 - Mariam's Defense
Date: 2024-04-08   Filed under: News

We are thrilled to announce that Mariam has successfully completed her PhD! Her research focused on the complement system, particularly the C7 component, which is vital for forming the membrane attack complex (MAC). While C7's role in MAC assembly is well understood, Mariam explored its lesser-known functions.

Her key findings include: (1) C7's synthesis outside the liver, enabling localized regulation and tissue-specific roles; (2) its links to various diseases, emphasizing the need to study its non-canonical functions; (3) the development of monoclonal antibodies and a highly specific ELISA to measure C7; and (4) the discovery of a C7-clusterin (CLU) complex, suggesting multifunctional roles for C7 beyond MAC assembly.

Mariam's innovative work has deepened our understanding of C7 and created tools for future research. We are incredibly proud of her achievements and wish her great success in her career!

116 - IIT meets SANDOZ
Date: 2024-03-05   Filed under: News

During the visit, students were divided into small groups and introduced to Sandoz's overarching mission and vision, as well as the step-by-step development process of a generic drug. A highlight of the day was the guided tour of an analytical lab within the pharmaceutical development department, where students had the chance to ask questions about career opportunities and life in the pharmaceutical industry post-PhD. A lunch pack provided by Sandoz offered much-appreciated energy for the group.

The day was filled with valuable insights into the industrial sector as a potential alternative to academia and highlighted the importance of viewing science from a broader perspective.

115 - Final Joint HOROS & CORVOS Retreat
Date: 2024-02-24   Filed under: News

It is done. The last retreat funded by the PhD programmes of excellence HOROS and CORVOS in Obergurgl ended on the 16th of January.  After 6 days of inspiring talks, exciting discussions and extensive networking we are all back home with loaded minds and tired legs. Through sessions covering a vast variety of topics such as fungal and bacterial infections, antimicrobial resistance, complement and its indications in the clinic, anaphylatoxins and virology we heard speakers from an equally colourful diversity of laboratories from Austria, Germany, Denmark, Norway, Sweden, Hungary, France and Italy. On top of that, we also got the opportunity to dive into some of the working schemes of the industry with refreshing talks from Marco Grasse (Sandoz), Loek Willems and Erik Toonen (Hycult) and Mikkel-Ole Skjødt (Novo Nordisk). On Saturday evening, a thrilling round of “catch on the ice” rounded up the whole experience.

Even though being the last meeting of this kind, the Obergurgl retreat with its mix of scientific and social interaction, surely paved the way once more for numerous fruitful collaborations. Special thanks goes to Prof. Dr. Reinhard Würzner for making this possible and bringing us together since nine years.

Group picture

9 years of retreats

Ice skating

Scientific programme

114 - Summary Report: 7th International Conference on HUS
Date: 2023-12-31   Filed under: News

On December 20th, 2023 the 7th International Conference on Hemolytic Uremic Syndrome (HUS) brought together leading experts to discuss cutting-edge research and clinical advancements in the beautiful city of Innsbruck. The day began with an overview of the previous six HUS meetings by Würzner (Innsbruck), setting the stage for a robust program.

The morning session highlighted the role of Shiga toxins in HUS. Scheutz (Copenhagen) detailed the diverse arsenal of Shiga toxins and their association with disease. Brigotti (Bologna) presented on the roles of cleaved and uncleaved Shiga toxin 2 in eHUS pathogenesis, while Orth-Höller (Innsbruck) discussed its cleavage in the gut. The session concluded with Riedl-Khursigara (Boston) discussing complement-mediated endothelial damage in aHUS.

In the afternoon, Würzner revisited the development of Eculizumab, the first complement-targeting therapy for aHUS. Waldegger (Innsbruck) outlined modern treatment strategies, including optimal timing for Eculizumab use. Pediatric perspectives were provided by Cortina and Rosales (Innsbruck), who addressed therapies and outcomes in acute kidney injury. Huber (Innsbruck) presented a visionary proposal for an international eHUS biobank to facilitate global collaboration and research. The conference concluded with a special lecture by Würzner on new vaccinations for seniors, emphasizing their importance in a vulnerable population.

The event fostered meaningful discussions on HUS pathogenesis, diagnostics, treatment advancements, and the need for international data-sharing initiatives. It was a highly informative platform, providing valuable insights for researchers and clinicians alike.

Key Takeaways:

  • The critical roles of Shiga toxins and complement in HUS pathogenesis were extensively explored.
  • Modern treatment strategies, including Eculizumab, were discussed, with a focus on personalized care.
  • The importance of collaborative efforts, such as an eHUS biobank, was emphasized to drive future research and innovation.

This conference underscored the strides made in understanding HUS while identifying areas for further investigation, enhancing the collective effort to improve patient outcomes.

The Programme

horos news

Be up to date! Have a look at our most recent news.



121 - "Wü to go"
Date: 2024-12-07   Filed under: News

On the 23 September 2024 the HOROS Speaker Reinhard Würzner invited his local peers, colleagues and students to his farewell symposium to the scenic roof seminar room of the Medical University of Innsbruck at the Fritz-Pregl-Str. 3. International colleagues of the complement field were additionally invited to a scientific symposium in Obergurgl (See CORVOS.eu), but Christoph Schmidt gave an overview on Reinhard Würzner's role at the European Complement Network (founding ECN General Secretary 1997-2003 and ECN President 2017-2023) on site. The other two external speakers were Nicole van de Kar (who reported on Reinhard's role as the Chair of the Scientific committee of the VTEC 2014 in Amsterdam) and Birgit Willinger (who evaluated Reinhard's engagement in Austrian Society of Medical Mycology: founding ÖGMM President 2001-2006 & again ÖGMM President 2020-2022).

He himself wanted to have this symposium also as a scientific one and started with an introductory talk on "Vaccinations for seniors". This talk was then followed by greeting messages and talks of his companions, peers and students refering to their projects in immunology, bacteriology and mycology with some breaks: Anita Luckner-Hornischer spoke about Reinhard's organisation of the 19 Tyrolean vaccination days and pointed out that already the first Tyrolean vaccination day was organised by him, back in 2006. Guido Wollmann focused on Reinhard being a valued member of the Corona-Diagnostic Team at the Inst. of Virology during the pandemic, Cornelia Speth on multiple scientific collaborations between them on fungi and complement and Dorothee Orth-Höller on their combined projects on complement in E.coli-induced haemolytic-uraemic syndrome.

Reinhard role in teaching, the doctoral studies at the Med. univ. Innsruck und in the doctoral programmes IIT, HOROS and CORVOS, which he all chaired, was evaluated by Bernhard Flucher and  Florian Kronenberg, but also his former administrators and students.

Programme

CV Reinhard Würzner

Congratulations



120 - Final Dinner of HOROS
Date: 2024-11-24   Filed under: News

The final dinner of the HOROS (Host Response in Opportunistic Infections) PhD Programme of Excellence took place in the end of September 2024 in Innsbruck and marked the culmination of an outstanding academic journey. Established in 2014, the programme has played a crucial role in advancing research on host responses to opportunistic infections, fostering innovation and collaboration in the field. Over the course of the last decade, more than 40 doctoral students have been supported by the programme, who have gone on to make significant contributions in academia, research institutions, and healthcare settings worldwide. The programme's interdisciplinary approach, fostering collaboration between immunologists, microbiologists, and clinicians, has led to valuable insights into the mechanisms of opportunistic infections and their impact on public health.

The final dinner for the HOROS programme marked a momentous occasion, celebrating over a decade of excellence in education, research, and innovation. The programme has not only contributed to advancing scientific knowledge but has also fostered a supportive community of researchers dedicated to addressing critical issues in infectious disease. As the programme officially comes to a close, the legacy of HOROS will continue to influence future generations of researchers and public health professionals working on the frontlines of infectious disease.

The organizers extended their gratitude to the mentors, faculty, and collaborators whose guidance and support have been pivotal in the success of the programme. Special thanks were given to the PhD students and alumni whose passion and dedication have been the driving force behind the programme's accomplishments.



119 - Congratulations to Patricia on Her Successful PhD Defense!
Date: 2024-11-24   Filed under: News

Patricia has successfully defended her PhD thesis on the metabolic remodeling of Aspergillus fumigatus during iron starvation, addressing critical challenges in fighting invasive fungal infections.

Her research explored how A. fumigatus adapts to iron limitation during infection, focusing on key transcription factors (HapX and SrbA) and siderophore-mediated iron acquisition. Using genetic and biochemical approaches, Patricia identified novel iron-regulated pathways that may serve as potential virulence determinants. A major highlight of her work was investigating the link between acetyl-CoA metabolism and siderophore biosynthesis, uncovering new insights into fungal iron homeostasis.

Patricia’s findings advance our understanding of A. fumigatus and open new avenues for improving antifungal therapies. Congratulations, Patricia, on this remarkable achievement!



118 - We proudly present Mr. Eliott Lafon, PhD!
Date: 2024-11-10   Filed under: News

We are thrilled to announce the successful defense of Eliott Lafon's PhD thesis, which explored the intricate host-pathogen interactions during SARS-CoV-2 infections, with a focus on understanding the immune response and the impact of underlying conditions like cystic fibrosis.

Eliott's research investigated how immune components such as T cells, antibodies, and complement factors differ across disease severity, shedding light on the interplay between these responses during COVID-19. The work also analyzed immune responses elicited by early COVID-19 vaccines against emerging variants, providing valuable insights into vaccine efficacy. Additionally, Eliott developed advanced in vitro lung models to study the unique dynamics of SARS-CoV-2 infection in cystic fibrosis airways, aiming to uncover factors contributing to potential resistance mechanisms.

This comprehensive body of work addresses critical challenges in understanding SARS-CoV-2 biology and host susceptibility, paving the way for future studies and therapeutic advancements. Congratulations, Eliott, on this remarkable accomplishment!



117 - Mariam's Defense
Date: 2024-04-08   Filed under: News

We are thrilled to announce that Mariam has successfully completed her PhD! Her research focused on the complement system, particularly the C7 component, which is vital for forming the membrane attack complex (MAC). While C7's role in MAC assembly is well understood, Mariam explored its lesser-known functions.

Her key findings include: (1) C7's synthesis outside the liver, enabling localized regulation and tissue-specific roles; (2) its links to various diseases, emphasizing the need to study its non-canonical functions; (3) the development of monoclonal antibodies and a highly specific ELISA to measure C7; and (4) the discovery of a C7-clusterin (CLU) complex, suggesting multifunctional roles for C7 beyond MAC assembly.

Mariam's innovative work has deepened our understanding of C7 and created tools for future research. We are incredibly proud of her achievements and wish her great success in her career!





contact

PROGRAMME SPEAKER

Reinhard Würzner, M.D., Ph.D.
Schöpfstraße 41
A-6020 Innsbruck

horos@i-med.ac.at

Imprint

Partner
FWF INDEX W1253-B24